BIOMAT Database Logo BIOMAT Database Logo

No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes. 2003

Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
University Hospital/AKH, Vienna Medical University, A-1090 Vienna, Austria. engelbert.deusch@akh-wien.ac.at

The effects of cannabinoids (CB) that have been reported in various leukocyte populations were mainly immunosuppressive or immunomodulatory. Almost nothing is known, however, about direct interactions of cannabinoids with human polymorphonuclear cells (PMN), although m-RNA for the cannabinoid receptor-2 (CB(2)) was found in human PMN. In order to investigate a potential influence of cannabinoids on human PMN, the migration and phagocytosis of PMN were studied in the presence of Delta(9)-Tetrahydrocannabinol (Delta(9)-THC) at final concentrations between 10(-10) and 10(-5) M. No effect was detectable on these essential PMN functions; and besides, no CB(2)-receptor expression could be detected using the Western blotting technique. Thus, circulating human PMN from healthy individuals remain unaffected by Delta(9)-THC due to the absence of functional CB(2)-receptor expression.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D013759 Dronabinol A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. THC,Tetrahydrocannabinol,delta(9)-THC,9-ene-Tetrahydrocannabinol,Marinol,Tetrahydrocannabinol, (6a-trans)-Isomer,Tetrahydrocannabinol, (6aR-cis)-Isomer,Tetrahydrocannabinol, (6aS-cis)-Isomer,Tetrahydrocannabinol, Trans-(+-)-Isomer,Tetrahydrocannabinol, Trans-Isomer,delta(1)-THC,delta(1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol,9 ene Tetrahydrocannabinol,Tetrahydrocannabinol, Trans Isomer
D043885 Receptor, Cannabinoid, CB2 A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES. Cannabinoid Receptor CB2,CB2 Receptor,CB2, Cannabinoid Receptor,Receptor CB2, Cannabinoid,Receptor, CB2

Related Publications

Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Evidence for a direct anterior pituitary site of delta-9-tetrahydrocannabinol action.
November 1991, Pharmacology, biochemistry, and behavior,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns.
January 1972, Clinical pharmacology and therapeutics,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Delta-9-tetrahydrocannabinol on isolated human bronchioles.
July 1980, Archives internationales de pharmacodynamie et de therapie,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Effects of delta-9-tetrahydrocannabinol on mouse spleens.
August 1975, Research communications in chemical pathology and pharmacology,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
March 1976, Clinical pharmacology and therapeutics,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Respiratory effects of delta-9-tetrahydrocannabinol.
May 1975, Clinical pharmacology and therapeutics,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Evaluation of the Modulatory Effects of Minor Cannabinoids and Terpenes on Delta-9-Tetrahydrocannabinol Discrimination in Rats.
September 2023, Cannabis and cannabinoid research,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.
February 2003, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
August 2006, Therapeutic drug monitoring,
Engelbert Deusch, and Birgit Kraft, and Gabriele Nahlik, and Lukas Weigl, and Martin Hohenegger, and Hans Georg Kress
Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
November 1986, Neuropharmacology,
Copied contents to your clipboard!